Kabziński Jacek, Walczak Anna, Mik Michał, Majsterek Ireneusz
Zakład Chemii i Biochemii Klinicznej, Uniwersytet Medyczny w Łodzi.
Klinika Chirurgii Ogólnej i Kolorektalnej, Uniwersytet Medyczny w Łodzi.
Pol Przegl Chir. 2019 Nov 4;92(1):1-4. doi: 10.5604/01.3001.0013.5539.
Colorectal cancer (CRC) is one of the most common malignant tumors. One of the factors increasing the risk of its occurrence may be the reduced efficiency of repairing DNA damage, both nuclear and mitochondrial. The main mechanism for repairing oxidative damage is the BER system (in mitochondria mtBER), whose key proteins NEIL1, NEIL2, OGG1, MUTYH, APE1 and LIG3 obtain full efficiency only at the appropriate level of acetylation. Sirtuin 3 is a key protein for mitochondrial homeostasis, regulating a number of metabolic processes related mainly to the control of the level of reactive oxygen species. Because Sirt3 possesses acetylase activity, it can modulate the level of activity of mtBER proteins by their deacetylation. The conducted study showed that the tested proteins NEIL1, NEIL2, OGG1, MUTYH, APE1 and LIG3 are the substrate for the enzymatic deacetylation activity of Sirt3, which may lead to modulation of the risk of CRC, and in cancer cells may be a potential therapeutic target enhancing the action of cytostatic drugs.
结直肠癌(CRC)是最常见的恶性肿瘤之一。其发生风险增加的因素之一可能是核DNA和线粒体DNA损伤修复效率降低。修复氧化损伤的主要机制是碱基切除修复(BER)系统(线粒体中为mtBER),其关键蛋白NEIL1、NEIL2、OGG1、MUTYH、APE1和LIG3只有在适当的乙酰化水平下才能发挥全部效率。沉默调节蛋白3是线粒体稳态的关键蛋白,调节许多主要与活性氧水平控制相关的代谢过程。由于Sirt3具有乙酰化酶活性,它可以通过使mtBER蛋白去乙酰化来调节其活性水平。所进行的研究表明,测试的蛋白NEIL1、NEIL2、OGG1、MUTYH、APE1和LIG3是Sirt3酶促去乙酰化活性的底物,这可能导致结直肠癌风险的调节,并且在癌细胞中可能是增强细胞毒性药物作用的潜在治疗靶点。